NEW YORK (GenomeWeb News) – Molecular dermatology company PharmaGenoma said today that it has signed up Svenson Haar Studios to distribute its HairDx subsidiary’s genetic test to predict the likelihood of a common type of hair loss.

Svenson will distribute the HairDx test, which provides a gene-based analysis of the chances that men and women will develop androgenetic alopecia, through a network of 17 centers throughout Germany.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.